Voices of 2012: A look at some of our best interviews of the year

"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." — Novation CEO Jody Hatcher

Read the full interview with Novation CEO Jody Hatcher

"I never get up in the morning and look at stock price and say that it’s a measure of success. There was a long time when the stock was at $3 and that was never a measure of failure, either. When I get up in the morning, the number 1 thing I care about is whether we are creating products that, in the hands of surgeons, are creating better value for patients. At Intuitive, we try to look at that with cold, hard facts." — Novation CEO Jody Hatcher

Read the full interview with Gary Guthart

View the full the list.

"I look at cost reduction as an ongoing exercise. So guess what? In the next 5 years, there’ll be another 25% target, so this is not going to go away." — Medtronic CEO Omar Ishrak

Read the full interview with Omar Ishrak

"Doctors used to play a very meaningful role in the advancement of medicine and, while it might sound heretical for me to say this, they’ve been marginalized. If you don’t believe me, then go to your doctor and ask them what they think.." — Strathspey Crown Chairman Robert Grant

Read the full interview with Robert Grant

"If you want to start going after the consumer you must hire the people with that background and bring them in. If they don’t have a medical device background, teach them medical device. But encourage them to bring that approach, technique, discipline. You have no shot at the consumer if you don’t have those skills in the company and you are likely to waste both time and money." — Align Technology CEO Tom Prescott

Read the full interview with Tom Prescott

"My experience has been that, basically, innovation can trump a lot of economic headwinds." — Allergan CEO David Pyott

Read the full interview with David Pyott

"There are a lot of great people at Stryker. I think my exit was an unfortunate and unfair experience. To me it was unfair, unfortunate and personally challenging." — sBioMed CEO and former Stryker CEO Stephen MacMillan

Read the full interview with Stephen MacMillan

"I think democracy requires people to get involved, I believe we have to stay engaged in our democracy. Otherwise it doesn’t survive and other people run off with it." — Masimo CEO Joe Kiani

Read the full interview with Joe Kiani

"Innovation starts with a creative spark—but that spark turns into a great invention only if the right conditions are in place. Steady financing and a smart, highly skilled team are critical. The government also plays a critical role in speeding – or slowing – the pace of innovation. Three changes in government policy are essential: a more efficient regulatory system at the FDA, repeal of the medical device tax, and an increased national commitment to research and education." — Senator-Elect Elizabeth Warren

Read Sen.-elect Warren’s op-ed


RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply